FNDC1.md
... ...
@@ -1,11 +1,12 @@
1
-# [FNDC1]
1
+# FNDC1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |2.80 |
15 16
|DLBCL |Chapuy cohort |2.56 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FOXC1.md
... ...
@@ -1,11 +1,12 @@
1
-# [FOXC1]
1
+# FOXC1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.20 |
15 16
|DLBCL |Chapuy cohort |0.85 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FOXO1.md
... ...
@@ -1,13 +1,14 @@
1
-# [FOXO1]
1
+# FOXO1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|BL |1 |high-confidence BL gene |
8 8
|DLBCL |1 |high-confidence DLBCL gene|
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort | 2.14 |
21 22
|FL |GAMBL genomes |12.93 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FOXP1.md
... ...
@@ -1,11 +1,12 @@
1
-# [FOXP1]
1
+# FOXP1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |2.10 |
15 16
|DLBCL |Chapuy cohort |2.99 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FTCD.md
... ...
@@ -1,11 +1,12 @@
1
-# [FTCD]
1
+# FTCD
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort | NA |
14 15
|BL |Panea cohort | NA |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FUBP1.md
... ...
@@ -1,11 +1,12 @@
1
-# [FUBP1]
1
+# FUBP1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.50 |
15 16
|DLBCL |Chapuy cohort |0.85 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FUT5.md
... ...
@@ -1,11 +1,12 @@
1
-# [FUT5]
1
+# FUT5
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |0.30 |
15 16
|DLBCL |Chapuy cohort |1.28 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FZD3.md
... ...
@@ -1,11 +1,12 @@
1
-# [FZD3]
1
+# FZD3
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort |0.00 |
14 15
|BL |Panea cohort |1.00 |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
FZR1.md
... ...
@@ -1,17 +1,18 @@
1
-# [FZR1]
1
+# FZR1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|FL |2 |relevance in FL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|FL |GAMBL genomes|1.15 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GABRA2.md
... ...
@@ -1,11 +1,12 @@
1
-# [GABRA2]
1
+# GABRA2
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.20 |
15 16
|DLBCL |Chapuy cohort |1.28 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GAK.md
... ...
@@ -1,11 +1,12 @@
1
-# [GAK]
1
+# GAK
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.90 |
15 16
|DLBCL |Chapuy cohort |2.56 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GBP7.md
... ...
@@ -1,17 +1,18 @@
1
-# [GBP7]
1
+# GBP7
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|FL |2 |relevance in FL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|FL |GAMBL genomes|0.23 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GGTLA4.md
... ...
@@ -1,11 +1,12 @@
1
-# [GGTLA4]
1
+# GGTLA4
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort |NA |
14 15
|BL |Panea cohort |NA |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|
19 20
GNA13.md
... ...
@@ -1,13 +1,14 @@
1
-# [GNA13]
1
+# GNA13
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|BL |1 |high-confidence BL gene |
8 8
|DLBCL |1 |high-confidence DLBCL gene|
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |10.26 |
21 22
|FL |GAMBL genomes |10.16 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GNAI2.md
... ...
@@ -1,13 +1,14 @@
1
-# [GNAI2]
1
+# GNAI2
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|BL |1 |high-confidence BL gene |
8 8
|DLBCL |1 |high-confidence DLBCL gene|
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort | 3.85 |
21 22
|FL |GAMBL genomes | 4.16 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GNAS.md
... ...
@@ -1,11 +1,12 @@
1
-# [GNAS]
1
+# GNAS
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.90 |
15 16
|DLBCL |Chapuy cohort |1.28 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GOLGA5.md
... ...
@@ -1,11 +1,12 @@
1
-# [GOLGA5]
1
+# GOLGA5
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.90 |
15 16
|DLBCL |Chapuy cohort |1.28 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GPC5.md
... ...
@@ -1,11 +1,12 @@
1
-# [GPC5]
1
+# GPC5
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |2.20 |
15 16
|DLBCL |Chapuy cohort |0.85 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GRB2.md
... ...
@@ -1,12 +1,13 @@
1
-# [GRB2]
1
+# GRB2
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:---------------------:|:-------------:|
... ...
@@ -18,7 +19,7 @@
18 19
|DLBCL |Reddy cohort |1.50 |
19 20
|DLBCL |Chapuy cohort |2.99 |
20 21
21
-## Mutation pattern
22
+## Mutation pattern and selective pressure estimates
22 23
23 24
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
24 25
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GRHPR.md
... ...
@@ -1,11 +1,14 @@
1
+# GRHPR
2
+## Overview
1 3
GRHPR is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus.
2 4
3
-## Mutation tier
5
+## Relevance tier by entity
4 6
5 7
|Entity|Tier|Description |
6 8
|:------:|:----:|--------------------------|
7 9
|DLBCL |1-a | aSHM target and high-confidence DLBCL gene|
8
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 12
10 13
|Entity|source |frequency (%)|
11 14
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +17,7 @@ GRHPR is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
14 17
|DLBCL |Reddy cohort |3.60 |
15 18
|DLBCL |Chapuy cohort |4.70 |
16 19
17
-## Mutation pattern
20
+## Mutation pattern and selective pressure estimates
18 21
19 22
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 23
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GRIK5.md
... ...
@@ -1,11 +1,12 @@
1
-# [GRIK5]
1
+# GRIK5
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort | NA |
14 15
|BL |Panea cohort | NA |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GRIN2A.md
... ...
@@ -1,17 +1,18 @@
1
-# [GRIN2A]
1
+# GRIN2A
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|---------------------------------------|
7 7
|MCL |2 |relevance in MCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|MCL |GAMBL genomes|0.47 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GRM6.md
... ...
@@ -1,17 +1,18 @@
1
-# [GRM6]
1
+# GRM6
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|FL |2 |relevance in FL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|FL |GAMBL genomes|0.92 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GSG2.md
... ...
@@ -1,11 +1,12 @@
1
-# [GSG2]
1
+# GSG2
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.50 |
15 16
|DLBCL |Chapuy cohort |2.14 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
GTSE1.md
... ...
@@ -1,11 +1,12 @@
1
-# [GTSE1]
1
+# GTSE1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort | NA |
14 15
|BL |Panea cohort | NA |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HDAC7.md
... ...
@@ -1,11 +1,12 @@
1
-# [HDAC7]
1
+# HDAC7
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |2.10 |
15 16
|DLBCL |Chapuy cohort |2.56 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HEPH.md
... ...
@@ -1,17 +1,18 @@
1
-# [HEPH]
1
+# HEPH
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|---------------------------------------|
7 7
|MCL |2 |relevance in MCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|MCL |GAMBL genomes|0.95 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H1B.md
... ...
@@ -1,13 +1,14 @@
1
-# [HIST1H1B]
1
+# HIST1H1B
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |9.83 |
21 22
|FL |GAMBL genomes |5.54 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H1C.md
... ...
@@ -1,13 +1,14 @@
1
-# [HIST1H1C]
1
+# HIST1H1C
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |12.39 |
21 22
|FL |GAMBL genomes | 5.08 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H1D.md
... ...
@@ -1,13 +1,14 @@
1
-# [HIST1H1D]
1
+# HIST1H1D
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |7.69 |
21 22
|FL |GAMBL genomes |3.23 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H1E.md
... ...
@@ -1,13 +1,14 @@
1
-# [HIST1H1E]
1
+# HIST1H1E
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |11.54 |
21 22
|FL |GAMBL genomes |12.93 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2AC.md
... ...
@@ -1,12 +1,13 @@
1
-# [HIST1H2AC]
1
+# HIST1H2AC
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8 8
|FL |1 |high-confidence FL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:--------------:|:-------------:|
... ...
@@ -16,7 +17,7 @@
16 17
|DLBCL |Chapuy cohort |6.41 |
17 18
|FL |GAMBL genomes |2.31 |
18 19
19
-## Mutation pattern
20
+## Mutation pattern and selective pressure estimates
20 21
21 22
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
22 23
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2AG.md
... ...
@@ -1,13 +1,14 @@
1
-# [HIST1H2AG]
1
+# HIST1H2AG
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established |
8 8
|DLBCL |2 |relevance in DLBCL not firmly established|
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |2.99 |
21 22
|FL |GAMBL genomes |2.08 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2AM.md
... ...
@@ -1,13 +1,14 @@
1
-# [HIST1H2AM]
1
+# HIST1H2AM
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |5.98 |
21 22
|FL |GAMBL genomes |3.70 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2BC.md
... ...
@@ -1,12 +1,13 @@
1
-# [HIST1H2BC]
1
+# HIST1H2BC
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8 8
|FL |1 |high-confidence FL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:--------------:|:-------------:|
... ...
@@ -16,7 +17,7 @@
16 17
|DLBCL |Chapuy cohort |5.56 |
17 18
|FL |GAMBL genomes |3.46 |
18 19
19
-## Mutation pattern
20
+## Mutation pattern and selective pressure estimates
20 21
21 22
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
22 23
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2BD.md
... ...
@@ -1,17 +1,18 @@
1
-# [HIST1H2BD]
1
+# HIST1H2BD
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------|
7 7
|FL |1 |high-confidence FL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|FL |GAMBL genomes|1.15 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2BG.md
... ...
@@ -1,17 +1,18 @@
1
-# [HIST1H2BG]
1
+# HIST1H2BG
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------|
7 7
|FL |1 |high-confidence FL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|FL |GAMBL genomes|2.08 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2BK.md
... ...
@@ -1,12 +1,13 @@
1
-# [HIST1H2BK]
1
+# HIST1H2BK
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:---------------------:|:-------------:|
... ...
@@ -18,7 +19,7 @@
18 19
|DLBCL |Reddy cohort |4.20 |
19 20
|DLBCL |Chapuy cohort |5.56 |
20 21
21
-## Mutation pattern
22
+## Mutation pattern and selective pressure estimates
22 23
23 24
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
24 25
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H2BM.md
... ...
@@ -1,17 +1,18 @@
1
-# [HIST1H2BM]
1
+# HIST1H2BM
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|FL |2 |relevance in FL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|FL |GAMBL genomes|0.69 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H3B.md
... ...
@@ -1,12 +1,13 @@
1
-# [HIST1H3B]
1
+# HIST1H3B
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8 8
|FL |1 |high-confidence FL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:--------------:|:-------------:|
... ...
@@ -16,7 +17,7 @@
16 17
|DLBCL |Chapuy cohort |2.14 |
17 18
|FL |GAMBL genomes |1.62 |
18 19
19
-## Mutation pattern
20
+## Mutation pattern and selective pressure estimates
20 21
21 22
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
22 23
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H3D.md
... ...
@@ -1,11 +1,12 @@
1
-# [HIST1H3D]
1
+# HIST1H3D
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort |1.70 |
14 15
|BL |Panea cohort |3.00 |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H3G.md
... ...
@@ -1,17 +1,18 @@
1
-# [HIST1H3G]
1
+# HIST1H3G
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------|
7 7
|FL |1 |high-confidence FL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:-------------:|:-------------:|
12 13
|FL |GAMBL genomes|1.62 |
13 14
14
-## Mutation pattern
15
+## Mutation pattern and selective pressure estimates
15 16
16 17
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
17 18
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H3H.md
... ...
@@ -1,11 +1,12 @@
1
-# [HIST1H3H]
1
+# HIST1H3H
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort |1.30 |
14 15
|BL |Panea cohort |5.90 |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H3I.md
... ...
@@ -1,12 +1,13 @@
1
-# [HIST1H3I]
1
+# HIST1H3I
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|FL |2 |relevance in FL not firmly established|
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:---------------------:|:-------------:|
... ...
@@ -15,7 +16,7 @@
15 16
|BL |Panea cohort |2.00 |
16 17
|FL |GAMBL genomes |1.15 |
17 18
18
-## Mutation pattern
19
+## Mutation pattern and selective pressure estimates
19 20
20 21
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
21 22
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H3J.md
... ...
@@ -1,11 +1,12 @@
1
-# [HIST1H3J]
1
+# HIST1H3J
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort |1.70 |
14 15
|BL |Panea cohort |5.00 |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST1H4J.md
... ...
@@ -1,11 +1,12 @@
1
-# [HIST1H4J]
1
+# HIST1H4J
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort |0.40 |
14 15
|BL |Panea cohort | NA |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HIST2H2BE.md
... ...
@@ -1,11 +1,12 @@
1
-# [HIST2H2BE]
1
+# HIST2H2BE
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |2.60 |
15 16
|DLBCL |Chapuy cohort |2.99 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HLA-A.md
... ...
@@ -1,12 +1,13 @@
1
-# [HLA-A]
1
+# HLA-A
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:---------------------:|:-------------:|
... ...
@@ -18,7 +19,7 @@
18 19
|DLBCL |Reddy cohort | 0.20 |
19 20
|DLBCL |Chapuy cohort | 8.97 |
20 21
21
-## Mutation pattern
22
+## Mutation pattern and selective pressure estimates
22 23
23 24
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
24 25
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HLA-B.md
... ...
@@ -1,13 +1,14 @@
1
-# [HLA-B]
1
+# HLA-B
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9 9
|FL |2 |relevance in FL not firmly established|
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |10.68 |
21 22
|FL |GAMBL genomes | 3.46 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HLA-C.md
... ...
@@ -1,11 +1,12 @@
1
-# [HLA-C]
1
+# HLA-C
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort | NA |
15 16
|DLBCL |Chapuy cohort |4.70 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HLA-DMA.md
... ...
@@ -1,11 +1,12 @@
1
-# [HLA-DMA]
1
+# HLA-DMA
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort | NA |
15 16
|DLBCL |Chapuy cohort |1.71 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HLA-DMB.md
... ...
@@ -1,12 +1,13 @@
1
-# [HLA-DMB]
1
+# HLA-DMB
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:---------------------:|:-------------:|
... ...
@@ -18,7 +19,7 @@
18 19
|DLBCL |Reddy cohort | NA |
19 20
|DLBCL |Chapuy cohort |1.71 |
20 21
21
-## Mutation pattern
22
+## Mutation pattern and selective pressure estimates
22 23
23 24
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
24 25
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HLA-DQA1.md
... ...
@@ -1,11 +1,12 @@
1
-# [HLA-DQA1]
1
+# HLA-DQA1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |0.30 |
15 16
|DLBCL |Chapuy cohort |1.28 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HLA-DQB1.md
... ...
@@ -1,11 +1,12 @@
1
-# [HLA-DQB1]
1
+# HLA-DQB1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort |NA |
14 15
|BL |Panea cohort |NA |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HNF1B.md
... ...
@@ -1,11 +1,12 @@
1
-# [HNF1B]
1
+# HNF1B
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |0.30 |
15 16
|DLBCL |Chapuy cohort |0.85 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HNRNPD.md
... ...
@@ -1,12 +1,13 @@
1
-# [HNRNPD]
1
+# HNRNPD
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene |
8 8
|FL |2 |relevance in FL not firmly established|
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:--------------:|:-------------:|
... ...
@@ -16,7 +17,7 @@
16 17
|DLBCL |Chapuy cohort |0.85 |
17 18
|FL |GAMBL genomes | NA |
18 19
19
-## Mutation pattern
20
+## Mutation pattern and selective pressure estimates
20 21
21 22
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
22 23
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HNRNPH1.md
... ...
@@ -1,12 +1,13 @@
1
-# [HNRNPH1]
1
+# HNRNPH1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8 8
|MCL |1 |high-confidence MCL gene |
9
-## Mutation incidence
9
+
10
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 11
11 12
|Entity|source |frequency (%)|
12 13
|:------:|:--------------:|:-------------:|
... ...
@@ -16,7 +17,7 @@
16 17
|DLBCL |Chapuy cohort |3.42 |
17 18
|MCL |GAMBL genomes |3.79 |
18 19
19
-## Mutation pattern
20
+## Mutation pattern and selective pressure estimates
20 21
21 22
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
22 23
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HNRNPU.md
... ...
@@ -1,12 +1,15 @@
1
+# HNRNPU
2
+## Overview
1 3
HNRNPU is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus.
2 4
3
-## Mutation tier
5
+## Relevance tier by entity
4 6
5 7
|Entity|Tier|Description |
6 8
|:------:|:----:|--------------------------|
7 9
|BL |1-a | aSHM target and high-confidence BL gene |
8 10
|DLBCL |1-a | aSHM target and high-confidence DLBCL gene|
9
-## Mutation incidence
11
+
12
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 13
11 14
|Entity|source |frequency (%)|
12 15
|:------:|:---------------------:|:-------------:|
... ...
@@ -18,7 +21,7 @@ HNRNPU is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm
18 21
|DLBCL |Reddy cohort |2.40 |
19 22
|DLBCL |Chapuy cohort |3.42 |
20 23
21
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
22 25
23 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
24 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HNRNPU.pdf
... ...
Binary files /dev/null and b/HNRNPU.pdf differ
HRAS.md
... ...
@@ -1,11 +1,12 @@
1
-# [HRAS]
1
+# HRAS
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |0.70 |
15 16
|DLBCL |Chapuy cohort |0.43 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
HVCN1.md
... ...
@@ -1,13 +1,14 @@
1
-# [HVCN1]
1
+# HVCN1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8 8
|DLBCL |1 |high-confidence DLBCL gene |
9 9
|FL |1 |high-confidence FL gene |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort |3.42 |
21 22
|FL |GAMBL genomes |6.47 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
ICK.md
... ...
@@ -1,11 +1,12 @@
1
-# [ICK]
1
+# ICK
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------------------|
7 7
|BL |2 |relevance in BL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:---------------------:|:-------------:|
... ...
@@ -13,7 +14,7 @@
13 14
|BL |Thomas cohort | NA |
14 15
|BL |Panea cohort | NA |
15 16
16
-## Mutation pattern
17
+## Mutation pattern and selective pressure estimates
17 18
18 19
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
19 20
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
ID3.md
... ...
@@ -1,13 +1,14 @@
1
-# [ID3]
1
+# ID3
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|BL |1-a | aSHM target and high-confidence BL gene |
8 8
|DLBCL |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |
9 9
|FL |2-a | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort | 0.85 |
21 22
|FL |GAMBL genomes | 0.92 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IER2.md
... ...
@@ -1,11 +1,12 @@
1
-# [IER2]
1
+# IER2
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |0.60 |
15 16
|DLBCL |Chapuy cohort |1.28 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IFNGR1.md
... ...
@@ -1,11 +1,12 @@
1
-# [IFNGR1]
1
+# IFNGR1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.40 |
15 16
|DLBCL |Chapuy cohort | NA |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IGLL5.md
... ...
@@ -1,13 +1,14 @@
1
-# [IGLL5]
1
+# IGLL5
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|BL |2-a | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous |
8 8
|DLBCL |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |
9 9
|FL |2-a | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous |
10
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
11 12
12 13
|Entity|source |frequency (%)|
13 14
|:------:|:---------------------:|:-------------:|
... ...
@@ -20,7 +21,7 @@
20 21
|DLBCL |Chapuy cohort | 8.97 |
21 22
|FL |GAMBL genomes |35.33 |
22 23
23
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
24 25
25 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
26 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IKBKB.md
... ...
@@ -1,11 +1,12 @@
1
-# [IKBKB]
1
+# IKBKB
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.10 |
15 16
|DLBCL |Chapuy cohort |3.42 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IKBKE.md
... ...
@@ -1,11 +1,12 @@
1
-# [IKBKE]
1
+# IKBKE
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.00 |
15 16
|DLBCL |Chapuy cohort |2.14 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IKZF3.md
... ...
@@ -1,12 +1,15 @@
1
+# IKZF3
2
+## Overview
1 3
IKZF3 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus.
2 4
3
-## Mutation tier
5
+## Relevance tier by entity
4 6
5 7
|Entity|Tier|Description |
6 8
|:------:|:----:|--------------------------------------|
7 9
|BL |2-a | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous |
8 10
|DLBCL |1-a | aSHM target and high-confidence DLBCL gene |
9
-## Mutation incidence
11
+
12
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
10 13
11 14
|Entity|source |frequency (%)|
12 15
|:------:|:---------------------:|:-------------:|
... ...
@@ -18,7 +21,7 @@ IKZF3 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
18 21
|DLBCL |Reddy cohort |3.90 |
19 22
|DLBCL |Chapuy cohort |4.27 |
20 23
21
-## Mutation pattern
24
+## Mutation pattern and selective pressure estimates
22 25
23 26
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
24 27
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IL16.md
... ...
@@ -1,11 +1,12 @@
1
-# [IL16]
1
+# IL16
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|--------------------------|
7 7
|DLBCL |1 |high-confidence DLBCL gene|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |2.80 |
15 16
|DLBCL |Chapuy cohort |5.13 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IL4R.md
... ...
@@ -1,11 +1,14 @@
1
+# IL4R
2
+## Overview
1 3
IL4R is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus.
2 4
3
-## Mutation tier
5
+## Relevance tier by entity
4 6
5 7
|Entity|Tier|Description |
6 8
|:------:|:----:|--------------------------|
7 9
|DLBCL |1-a | aSHM target and high-confidence DLBCL gene|
8
-## Mutation incidence
10
+
11
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 12
10 13
|Entity|source |frequency (%)|
11 14
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +17,7 @@ IL4R is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
14 17
|DLBCL |Reddy cohort |2.50 |
15 18
|DLBCL |Chapuy cohort |3.85 |
16 19
17
-## Mutation pattern
20
+## Mutation pattern and selective pressure estimates
18 21
19 22
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 23
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IL6.md
... ...
@@ -1,11 +1,12 @@
1
-# [IL6]
1
+# IL6
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.20 |
15 16
|DLBCL |Chapuy cohort |1.71 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
INO80.md
... ...
@@ -1,11 +1,12 @@
1
-# [INO80]
1
+# INO80
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |2.50 |
15 16
|DLBCL |Chapuy cohort |3.42 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
IRAG2.md
... ...
@@ -1,11 +1,12 @@
1
-# [IRAG2]
1
+# IRAG2
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2 |relevance in DLBCL not firmly established|
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |NA |
15 16
|DLBCL |Chapuy cohort |NA |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|
20 21
IRF1.md
... ...
@@ -1,11 +1,12 @@
1
-# [IRF1]
1
+# IRF1
2 2
3
-## Mutation tier
3
+## Relevance tier by entity
4 4
5 5
|Entity|Tier|Description |
6 6
|:------:|:----:|-----------------------------------------|
7 7
|DLBCL |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |
8
-## Mutation incidence
8
+
9
+## Mutation incidence in large patient cohorts (GAMBL reanalysis)
9 10
10 11
|Entity|source |frequency (%)|
11 12
|:------:|:--------------:|:-------------:|
... ...
@@ -14,7 +15,7 @@
14 15
|DLBCL |Reddy cohort |1.90 |
15 16
|DLBCL |Chapuy cohort |2.56 |
16 17
17
-## Mutation pattern
18
+## Mutation pattern and selective pressure estimates
18 19
19 20
|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
20 21
|:------:|:----:|:---------------------:|:----------------:|:----------------:|